Saturday, June 25, 2022

Insider Selling: Kornitzer Benjamin, agilon health inc. [AGL] Chief Med. & Quality Officer divested 5,396 shares

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. agilon health inc. shares valued at $104,296 were sold by Kornitzer Benjamin on Jun 10. At $19.33 per share, Kornitzer Benjamin sold 5,396 shares. The insider’s holdings dropped to 10,853 shares worth approximately $0.22 million following the completion of this transaction.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


Also, Kornitzer Benjamin sold 5,396 shares, netting a total of over 112,767 in proceeds. Following the sale of shares at $20.90 each, the insider now holds 10,853 shares.

Before that, Kornitzer Benjamin had sold 5,396 shares from its account. In a trade valued at $106,679, the Chief Med. & Quality Officer traded agilon health inc. shares for $19.77 each. Upon closing the transaction, the insider’s holdings decreased to 5,396 shares, worth approximately $0.22 million.

As published in their initiating research note from Guggenheim on March 30, 2022, agilon health inc. [AGL] has been a Buy and the price target has been revised to $32. This represents a 37.53% premium over Wednesday’s closing price. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in mid October. As of September 27, 2021, SVB Leerink has initiated its “an Outperform” rating for AGL. Earlier on September 10, 2021, Cowen initiated its rating. Their recommendation was “an Outperform” for AGL stock.

Analyzing AGL’s Price Performance

On Wednesday, agilon health inc. [NYSE: AGL] rose 0.76% to $19.99. The stock’s lowest price that day was $19.403, but it reached a high of $20.40 in the same session. During the last five days, there has been a surge of approximately 6.50%. Over the course of the year, agilon health inc. shares have dropped approximately -25.96%. Shares of the company reached a 52-week high of $27.77 on 01/03/22 and a 52-week low of $14.36 on 01/28/22. A 50-day SMA is recorded $19.45, while a 200-day SMA reached $22.45. Nevertheless, trading volume fell to 1.38 million shares from 1.39 million shares the previous day.

Support And Resistance Levels for agilon health inc. (AGL)

According to the 24-hour chart, there is a support level at 19.46, which, if violated, would cause prices to drop to 18.93. In the upper region, resistance lies at 20.46. The next price resistance is at 20.93. RSI (Relative Strength Index) is 53.50 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.10, which suggests the price will decrease in the coming days. Percent R is at 38.57%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Is agilon health inc. subject to short interest?

Stocks of agilon health inc. saw a sharp rise in short interest on Apr 28, 2022 jumping by 2.48 million shares to 17.1 million. Data from Yahoo Finance shows that the short interest on Mar 30, 2022 was 14.62 million shares. A jump of 14.5% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 12.59 of the overall float, the days-to-cover ratio (short ratio) jumped to 12.59.

Which companies own the most shares of agilon health inc. (AGL)?

According to Capital Research & Management Co filings, the company currently owns 36,322,390 shares, which is about 8.93% of the total AGL shares outstanding. The investor’s shares have appreciated by 456,437 from its previous 13-F filing of 35865953.0 shares. With the completion of the buy, Morgan Stanley Investment Managem’s stake is now worth $667,251,853. Fidelity Management & Research Co acquire a 46.83% interest valued at $553.28 million while Wellington Management Co. LLP purchased a 1,834,890 stake. A total of 185,362 shares of agilon health inc. were bought by The Vanguard Group, Inc. during the quarter, and 1,536,506 were bought by Capital Research & Management Co. In its current portfolio, Morgan Stanley Investment Managem holds 8,340,024 shares valued at $159.29 million.

In terms of agilon health inc. share price expectations, FactSet research, analysts set an average price target of $31.00 in the next 12 months, up nearly 53.73% from the previous closing price of $19.84. Analysts anticipate agilon health inc. stock to reach $41.00 by 2022, with the lowest price target being $23.00. In spite of this, 11 analysts ranked agilon health inc. stock as a Buy at the end of 2022.

Latest news

Related news

LEAVE A REPLY

Please enter your comment!
Please enter your name here

2618

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam